325 - Direct Impact of Pediatric Immunization on Reduction in Antibiotic Prescribing in the United States

Friday, October 18, 2024

12:30 PM – 12:35 PM US PT

Location: Halls JK - Arena 3

Co-Author(s)

JC

Justin Carrico, BS

Senior Research Health Economist
RTI Health Solutions
Research Triangle Park, North Carolina, United States
Sandra E. Talbird, MSPH

Senior Director, Health Economics
RTI Health Solutions
Research Triangle Park, North Carolina, United States

Rapid Fire Presenter(s)

Amanda Eiden, PhD, MBA, MPH (she/her/hers)

Director
Merck
Philadelphia, PA, United States

Co-Author(s)

Cristina Carias, PhD

Director
Merck & Co., Inc.
Rahway, New Jersey, United States
MH

Min Huang, PhD

Sr. Principal Scientist
Merck & Co., Inc.
Rahway, New Jersey, United States
John C. Lang, PhD, MSc, MSc, BSc (he/him/his)

Principal Scientist
Merck Canada Inc., Kirkland, QC, Canada
Kirkland, Quebec, Canada
Gary S. Marshall, MD

Professor of Pediatrics
Norton Children's and University of Louisville School of Medicine
Louisville, KY, United States
GB

Goran Bencina, PhD

MSD
Madrid, Madrid, Spain

Disclosure(s):

Justin Carrico, BS: Merck & Co., Inc.: Advisor/Consultant

Sandra E. Talbird, MSPH: Merck & Co., Inc.: Advisor/Consultant

Amanda Eiden, PhD, MBA, MPH: Merck & Co., Inc.: Stocks/Bonds (Private Company)

Cristina Carias, PhD: Merck & Co., Inc.: Stocks/Bonds (Private Company)

Min Huang, PhD: Merck & Co., Inc.: Employee, Stocks/Bonds (Public Company)

John C. Lang, PhD, MSc, MSc, BSc: Merck & Co., Inc.: Stocks/Bonds (Private Company); Merck Canada Inc.: Employee

Gary S. Marshall, MD: GSK: Advisor/Consultant (), Grant/Research Support (), Honoraria (); Merck & Co., Inc.: Advisor/Consultant (), Grant/Research Support (), Honoraria (); Moderna: Advisor/Consultant (), Honoraria (); Pfizer: Advisor/Consultant (), Grant/Research Support (), Honoraria (); Sanofi: Advisor/Consultant (), Grant/Research Support (), Honoraria (); Seqirus: Advisor/Consultant (), Grant/Research Support (), Honoraria ()

Goran Bencina, PhD: Merck & Co., Inc.: Stocks/Bonds (Private Company)